Targeting Rapamycin to Podocytes Using a Vascular Cell Adhesion Molecule-1 (VCAM-1)-Harnessed SAINT-Based Lipid Carrier System.
Together with mesangial cells, glomerular endothelial cells and the basement membrane, podocytes constitute the glomerular filtration barrier (GFB) of the kidney. Podocytes play a pivotal role in the progression of various kidney-related diseases such as glomerular sclerosis and glomerulonephritis t...
Main Authors: | Ganesh Ram R Visweswaran, Shima Gholizadeh, Marcel H J Ruiters, Grietje Molema, Robbert J Kok, Jan A A M Kamps |
---|---|
Format: | Article |
Language: | English |
Published: |
Public Library of Science (PLoS)
2015-01-01
|
Series: | PLoS ONE |
Online Access: | http://europepmc.org/articles/PMC4583306?pdf=render |
Similar Items
-
Endothelium-targeted delivery of dexamethasone by anti-VCAM-1 SAINT-O-Somes in mouse endotoxemia.
by: Ranran Li, et al.
Published: (2018-01-01) -
Rapamycin upregulates autophagy by inhibiting the mTOR-ULK1 pathway, resulting in reduced podocyte injury.
by: Lingling Wu, et al.
Published: (2013-01-01) -
Establishment of protein delivery systems targeting podocytes.
by: Wen Chih Chiang, et al.
Published: (2010-07-01) -
Rapamycin Reduces Podocyte Apoptosis and is Involved in Autophagy and mTOR/ P70S6K/4EBP1 Signaling
by: Juan Jin, et al.
Published: (2018-07-01) -
ICAM-1 Clustering on Endothelial Cells Recruits VCAM-1
by: Jaap D. van Buul, et al.
Published: (2010-01-01)